Synthesis and Biological Evaluation of Novel Substituted-Imidazolidine Derivatives
作者:Asif Husain、Rubina Bhutani、Deepak Kumar、Dong-Soo Shin
DOI:10.5012/jkcs.2013.57.2.227
日期:2013.4.20
A series of newer substituted-imidazolidine derivatives 3a-k were synthesized and assayed in vivo to investigate their anti-inflammatory, analgesic and antiulcer activity. The results of biological evaluation revealed that the three compounds, 4-[1,3-bis(4-hydroxy-3-methoxybenzyl)-2-imidazolidinyl]phenyldiethylamine (3g), 4-[1,3-bis(3-Ethoxy-4-hydroxybenzyl)-2-imidazolidinyl] phenyldiethylamine (3h) and 4-(1,3-bis(benzo[d][1,3]dioxol-5-ylmethyl)-4-methylimidazolidin-2-yl)-N,N-diethylbenzenamine (3j) were good in their anti-inflammatory and analgesic actions. Additionally these derivatives showed superior GI safety profile as compared to that of the standard drug in terms of low severity index. The results are statistically treated for its significance.
研究人员合成了一系列较新的取代咪唑烷衍生物 3a-k,并对其进行了体内试验,以研究它们的抗炎、镇痛和抗溃疡活性。生物学评价结果表明,4-[1,3-双(4-羟基-3-甲氧基苄基)-2-咪唑烷基]苯二乙胺(3g)、4-[1、3-双(3-乙氧基-4-羟基苄基)-2-咪唑烷基]苯基二乙胺(3h)和 4-(1,3-双(苯并[d][1,3]二恶茂-5-基甲基)-4-甲基咪唑烷-2-基)-N,N-二乙基苯胺(3j)具有良好的抗炎和镇痛作用。此外,与标准药物相比,这些衍生物在低严重指数方面显示出更优越的胃肠道安全性。这些结果经统计学处理,具有重要意义。